ReviewCureus2026
Digital Twins and Offline Reinforcement Learning for Mechanical Circulatory Support Decisions: What the Current Evidence Can and Cannot Support.
Review in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Mechanical circulatory support (MCS) is not a single intervention but a sequence of decisions: whether to initiate support, which device to use, how to titrate it while other therapies change, when to test for recovery, and whether to wean, escalate, bridge, or withdraw. Each decision has its own eligible population, time origin, action set, and cost of error. Interest is growing in patient-specific digital twins and offline reinforcement learning to support these decisions, and the first device-specific probabilistic twins and safety-regularized weaning policies have now been published. This narrative review examines what that literature currently establishes. Cardiac digital twins have produced their most convincing results in electrophysiology and resynchronization, where the modeled substrate is anatomically stable, and the intervention is discrete; circulatory support is harder because it involves a continuously titrated device acting on a rapidly changing patient under unrecorded co-interventions. The published MCS work is small, largely single-device, restricted to patients already receiving support, and evaluated against hemodynamic surrogate rewards inside simulators estimated from the same trajectories used for training. Three problems recur and appear to be the limiting factors rather than model capacity: predictive accuracy for an endpoint does not establish that an action is beneficial; a simulator cannot independently certify a policy optimized against it; and information available to a retrospective analyst is not information that was available at the decision time. The defensible near-term claim is improved state estimation and forecasting with calibrated uncertainty and explicit abstention. The initiation question requires target-trial emulation rather than a post-implant cohort, and public critical-care datasets can validate chronology and transport but cannot validate device titration or weaning policy.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.